Bordetella pertussis is a re-emerging human respiratory pathogen whose infectious process is not fully understood, hampering the design of effective vaccines. The nature of bacterial attachment to host cells is a key event in the outcome of the infection. However, host cell receptors involved in B. pertussis colonization of the respiratory tract are still under investigation. Here, we report that cholesterol-rich domains are involved in B. pertussis adhesion to epithelial cells. Treatment of A549 cells with cholesterol-sequestering drugs such as methyl-P-cyclodextrin, nystatin, or filipin resulted in a significant decrease ofB. pertussis attachment. Confocal laser microscopy studies showed B. pertussis associated with cholesterol-rich domains. Accordingly, B. pertussis was found in detergent-resistant membrane domain fractions isolated from bacterial-infected A549 cells. Our results indicate a main role of filamentous hemagglutinin, an environmentally regulated virulence factor, in this interaction, and a specific affinity for cholesterol, one of the major components of traqueal secretions, which might additionally contribute to the effective colonization of the respiratory tract.
Introduction
Bordetella pertussis is the etiologic agent of whooping cough, a re-emerging infectious disease. Upon entering the human host, the bacterium initiates the colonization of the respira tory tract by adhering to epithelial cells, which is a central phenomenon in the pathogenesis of B. pertussis. The inter action between virulent B. pertussis and the host involves several factors. Some of them are fairly well characterized, such as filamentous hemagglutinin (FHA), a major adhesin of this pathogen, and its docking molecules, namely lactosyl ceramides of ciliated respiratory cells (Prasad et al., 1993) , sulfated sugars at the surface of epithelial cells (Hannah et al., 1994) , and integrins in leukocytes (Reiman et al., 1990) . However, much of this interaction is still unknown.
In recent years, it has been recognized that a variety of pathogens interact with microdomains in the plasma mem brane known as lipid rafts, which eventually determines the outcome of the infection (Zaas et al., 2005) . Rafts are membrane microdomains enriched in cholesterol and glyco sphingolipids. Lipid rafts are characterized by their insolu bility in cold Triton X-100 and have thus been termed detergent-resistant membrane domains (DRMs). Because of their high lipid content, these detergent-insoluble do mains float to a low density during gradient centrifugation (Brown & Rose, 1992 ). An important feature of lipid rafts is their highly dynamic nature, which allows the transient formation of membrane platforms that build up molecular machineries implicated in cell signaling (Shaul & Anderson, 1998) and endocytosis (Nichols, 2003) . Several bacteria have been found to co-opt the mechanism of lipid rafts-mediated endocytosis in order to adhere, invade, and remain viable inside host cells (Zaas et al., 2005) . Likewise, we recently found plasma membrane cholesterol domains to play a crucial role in neutrophils (PMN) uptake of non-opsonized B. pertussis and bacterial intracellular survival (Lamberti etal., 2008) . Here we investigated whether cholesterol is also involved in B. pertussis interaction with epithelial respiratory cells. The results indicate that lipid rafts, and cholesterol itself, play a significant role in bacterial interaction with epithelial cells and FHA is a key factor in this process.
pCW505 (Weingart et al., 1999) (kindly supplied by Dr Weiss, Cincinnati, OH), which induces cytoplasmic expres sion of green fluorescent protein (GFP) without affecting growth or antigen expression (Weingart et al., 1999) . In some experiments, BPGR4, a Tohama-derived mutant lack ing expression of FHA (Locht et al., 1992) transformed with plasmid pCW505, was used. Bacteria were stored at -70 C and recovered by growth on Bordet Gengou agar (BGA) plates supplemented with 15% defibrinated sheep blood (bBGA) at 35 C for 3 days. Virulent bacteria were subse quently plated on bBGA, cultured for 20 h at 35 °C and used in adhesion assays.
In some experiments, Escherichia coli DH5a transformed with plasmid PML2, a pSMIO (Selbitschka et al., 1995) derivative, which induces cytoplasmic expression of GFP (a generous gift from Dr Lagares, Institute of Biochemistry and Molecular Biology, La Plata, Argentina), was used.
Cells and growth conditions
The human alveolar epithelial cell line A549 (human lung type II pneumocyte) (ATCC CCL185, Rockville, MD) was cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% of fetal bovine serum (FBS), lOOUml. 1 penicillin, and 100 mg ml. 1 streptomycin (Sigma, St. Louis, MO) at 37 °C in 5% CO2. Routine subcultures for A549 pneumocytes were performed at 1:3 split ratios by incubation with 0.05% trypsin-0.02% EDTA for 5 min at 37 C. For the Bordetella adherence assay, epithelial cells were cultured to 80% confluence.
Antibodies
The following antibodies were used: mouse monoclonal antibodies (mAbs) against human caveolin-1 (Pharmingen, San Diego, CA), mouse mAb against the human transferrin receptor (Pharmingen), and polyclonal rabbit antibody against human flotillin-1 (Santa Cruz Biotechnology, Santa Cruz, CA).
Immunoglobulin G (IgG) fractions from pooled sera of pertussis patients with high titers against B. pertussis, as measured by enzyme-linked immunosorbent assay (Nagel etal., 1985) , were isolated as described previously (Rodriguez et al., 2001) . Polyclonal mouse anti-FHA B. pertussis antiser um was generated as described before (Sato & Sato, 1984) .
Treatment of A549 cells with cholesterolaffecting drugs
Cholesterol sequestration was achieved by incubating A549 cells with 10 mM of methyl-P-cyclodextrin (MPCD) (Sigma) (15 min at 37 °C), or 35 pg ml. 1 of nystatin (Sigma) (30 min at 37 °C), or 5 pg ml. 1 of filipin (Sigma) (30 min at 37 °C) in serum-free DMEM medium plus bovine serum albumin (BSA) (0.2%) and lovastatin (5 pg ml. ') (Sigma) (DMEM-BSA-L). Cells were then washed, suspended in DMEM-BSA-L, and used immediately. No decrease in cell viability was detected after treatment as determined by trypan blue exclusion. In selected experiments, cholesterol replenishment was performed by incubation of MPCDtreated A549 cells with 8 mg ml. 1 of water soluble choles terol (Sigma) in DMEM-BSA for 30 min at 37 °C or with FBS (20%) in DMEM-BSA for 3 h at 37 °C.
Total cellular cholesterol in treated and untreated A549 cells was determined using the Amplex Red cholesterol assay kit (Molecular Probes). Under the experimental conditions used, the 54 ± 2% of total cellular cholesterol was removed by MPCD treatment. The cellular choles terol content was found to be restored (98 ±1%) upon replenishment.
Binding assays
Attachment assays were performed as described in Rodri guez et al. (2006) , with minor modifications. Briefly, cells were seeded on glass coverslips in 24-well tissue culture plates (Nunc, Rockside, Denmark) and incubated for 18 h. Monolayers were washed twice with sterile phosphatebuffered saline (PBS) and treated with or without cholester ol-affecting drugs as described above. Cells were then incubated with either GFP-expressing B. pertussis at a multi plicity of infection (MOI) of 150 bacteria per cell for 2h at 37 °C or 17 pg ml. 1 of purified native FHA (Glaxo SmithKline) in DMEM-BSA-L for 1 h at 37 °C. To facilitate bacterial interaction with epithelial cells, plates were centri fuged for 5 min at 640 g. No changes in the number of viable A549 cells were detected after incubation with either bacter ia or FHA. After incubation, the monolayers were washed with DMEM plus BSA (0.2%), before fixation with paraf ormaldehyde. The number of adherent bacteria per cell was estimated by fluorescence microscopy examination of 20 randomly selected fields showing a minimum of seven epithelial cells per field. The association of FHA with A549 cells was investigated both by fluorescence microscopy and by flow cytometry (Becton Dickinson, Lincoln Park, NJ). To this end, A549 cells treated with or without PBS-EDTA (0.2%) were incubated with anti-FHA mouse serum, fol lowed by incubation with an fluorescein isothiocyanateconjugated F(ab')2 fragment of goat anti-mouse IgG (Jackson ImmunoResearch, West Grove). All experiments were performed at least three times in duplicate.
In some experiments, GFP-expressing B. pertussis (6 x 106) were incubated with 1.8pgmL_1 of cholesterol (Sigma) in DMEM medium plus BSA (0.2%) for 1 h at 37 C. After three washing steps, bacteria were incubated with A549 cells at a MOI of 150.
In control experiments, attachment of GFP-expressing E. coli DH5a was evaluated as described above at a MOI of 500.
Cholesterol-binding studies
Bacterial cholesterol-binding capacity was investigated as described elsewhere (Rostand & Esko, 1993) with some modifications. Briefly, 1 pg of cholesterol diluted in ethanol was dried onto a microtiter plate at room temperature. Cholesterol-treated plates were then washed six times with PBS and blocked with 1% BSA in PBS for 1 h at 37 °C. Bacteria (wild type or BPGR4 strain) were added to the plates (2 x 107 bacteria per well) and incubated for 1 h at 37 C. Non-adherent bacteria were removed by three wash ing steps with PBS. Human IgG anti-B. pertussis antibody was added to each well, and plates were incubated at 30 C for 2 h. After three washing steps, anti-human IgG-peroxidase conjugate antibodies were added to each well. The plates were then incubated at 37 C for 2h. After three washing steps, the enzyme reaction was initiated by the addition of O-phenylene diamine (0.1 mg ml. ') and H2O2 (30 volumes in 100 mL citrate-phosphate buffer, pH 5). After 15 min in the dark at room temperature, the reaction was stopped by the addition of H2SO4 (4N). Bacteria attached to the wells were estimated by the A492nm. Wells coated with ethanol or blocking agent alone were used as control of nonspecific binding.
Cell fractionation and isolation of DRMs
DRMs of A549 cells incubated either with B. pertussis or FHA were isolated as follows: A549 cells (1 x 107 cells) grown at 80% confluence were incubated for 2h at 37 C with B. pertussis at a MOI of 150 bacteria per cell, or for 1 h at 37 °C with 17 pg ml. 1 of purified FHA. Triton-insoluble cell components were then isolated according to a previously published protocol (Chamberlain et al., 2001) . In brief, cells were washed twice with cold PBS and scraped from the dishes into PBS. The cell pellet was suspended in ice-cold Tris-buffered saline (TBS) (20 mM Tris, pH 7.4, 1 mM EDTA, and 140 mM NaCl) containing 1% Triton X-100, 1 mM phenylmethylsulfoxide, and 1% protease inhibitor cocktail (Sigma), and the cells were passaged 10 times through a 27G1/2 needle. The cell lysate was centrifuged at 800 g for 10 min at 4 C, and the postnuclear supernatant was adjusted to 40% sucrose in TBS, placed at the bottom of an SW41 centrifuge tube (Beckman Instruments) and layered with 6 mL of 30% sucrose in TBS and 3 mL of 5% sucrose in TBS. After centrifugation at 247 000g for 15 h at 4 C in a swinging bucket rotor (model SW41, Beckman Instruments), 1-mL fractions were collected from the top of the gradient (fraction 1) to the bottom (fraction 12). Proteins from each fraction were precipitated with 10% trichloroacetic acid in the presence of 0.02% sodium deox ycholate as a carrier. Samples were suspended in 50 pL of PBS and stored at -20 °C until use.
In some experiments, cells were treated with 0.5% Triton X-100 plus 0.5% saponin (Sigma), a lipid raft-disrupting drug.
Analysis of sucrose density-gradient fractions
Sucrose density-gradient fractions of cells incubated with or without B. pertussis were analyzed for the presence of bacteria, caveolin, and transferrin receptor by dot-blot assays as follows: equal volumes (10 pL) of each fraction were spotted onto polyvinylidene fluoride (Immobilon PVDF, Millipore) and allowed to dry. Membranes were incubated for 2 h at room temperature in a blocking solu tion (PBS, 5% BSA), and then exposed for 2 h at room temperature to mouse monoclonal anti-caveolin-1 antibo dies, mouse monoclonal anti-transferrin receptor antibo dies, or human IgG anti-B. pertussis antibodies. After washing, specific binding of antibodies was visualized using alkaline phosphatase-conjugated goat anti-mouse IgG (Jackson ImmunoResearch, Baltimore Pike) or alkaline phosphatase-conjugated goat anti-human IgG (Jackson Im munoResearch, Baltimore Pike) as secondary antibodies, and nitroblue tetrazolium/5-bromo-4-chloro-3-indolylphosphate (NBT/BCIP) (Bio-Rad) as a substrate.
Sucrose density-gradient fractions of cells incubated with or without FHA were analyzed by SDS-PAGE and immuno blotting. Fractions 1 and 2, 9 and 10, and 11 and 12 were pooled to allow immunoblot analysis of all gradient frac tions on a single polyacrylamide gel. Samples were sus pended in Laemmli sample buffer and run on 7% sodium dodecyl sulfate-polyacryilamide gel. Proteins were trans ferred to PVDF sheets (Towbin et al., 1979) and incubated with mouse polyclonal anti-FHA, mouse monoclonal anticaveolin-1, or mouse monoclonal anti-transferrin receptor antibodies. Immunochemical detection was performed using alkaline phosphatase-conjugated goat anti-mouse IgG and NBT/BCIP (Bio-Rad) as a substrate.
Confocal microscopy
A549 cells were incubated with B. pertussis expressing GFP (MOI, 100) at 37 °C for 2h. Nonadherent bacteria were removed by washing with PBS. Cells were then fixed using paraformaldehyde. After fixation, A549 cells were washed twice with PBS, and incubated for 10 min at room tempera ture with PBS containing 50 mM NH4C1. After two washing steps, cells were permeabilized by incubation with PBS containing 0.1% saponin and 0.5% BSA for 30 min. Next, cells were incubated overnight at 4 C with anti-flotillin antibodies in the presence of 0.1% saponin and 0.5% BSA. After three washing steps, cells were incubated with a CY-3-conjugated F(ab')2 fragment of goat anti-mouse IgG (Jackson ImmunoResearch, West Grove) for 30 min at 4 "C. To avoid cytophilic binding of antibodies, all incubations were performed in the presence of 25% heat-inactivated human serum. Microscopic analyses were performed using a confocal laser-scanning microscope (Olympus FV 300, Japan). The percentage of bacteria colocalizing with flotillin was calculated by analyzing at least 50 cells in randomly selected fields.
Statistical analysis
Student's f-test (confidence level, 95%) or anova was used for statistical data evaluation. The significance of the differ ences between the mean values of the data evaluated by anova was determined using the least significant difference test at a confidence level of 95%. Results are shown as means and SD.
Results and discussion
Adhesion is a central phenomenon in the pathogenesis of B. pertussis. Adhesins and their counterparts in host cells play a substantial role in determining the outcome of a prokar yotic-eukaryotic interaction. Recent observations highlighted the role of cholesterol-rich domains in microbial pathogeni city. Lipid rafts are involved in the attachment, cell entry, and intracellular survival of several microorganisms such as Brucella suis (Naroeni & Porte, 2002) , Chlamydia trachomatis (Jutras et al., 2003) , and Mycobacterium bovis (Gatfield & Pieters, 2000) . A recent report of our group showed that cholesterol-rich domains are involved in B. pertussis interac tion with human neutrophils and shape bacterial trafficking inside the immune cell, eventually leading to bacterial survi val (Lamberti et al., 2008) .
The ability of B. pertussis to adhere to the respiratory epithelium is pivotal in the subsequent development of infection. Here we investigated whether plasma membrane cholesterol is involved in this process. To this end, we used A549 cells, a human alveolar cell line previously used to study B. pertussis interaction with human respiratory epithe lial cells (Ishibashi et al., 2001; Perez Vidakovics et al., 2006; Rodriguez et al., 2006) . Cholesterol was depleted from cell plasma membrane by incubation with MPCD. Because MPCD does not interfere with cholesterol synthesis, the experiments described here were conducted in the presence of lovastatin, a drug that inhibits de novo cholesterol synthesis. As can be seen in Fig. 1 , cholesterol depletion resulted in a significant decrease of virulent B. pertussis attachment (55%). The role of cholesterol in this process was further confirmed by incubation of A549 cells with cholesterol-binding drugs such as nystatin or filipin. Cells treated with any of the latter drugs showed a significant Fig. 1 . Bordetella pertussis attachment to A549 cells is dependent on cholesterol. A549 cells treated without (control) or with 10mM of MpCD, 5 pg ml_ 1 of filipin, or 35 mg mL 1 of nystatin were incubated with GFP-expressing B. pertussis (MOI, 150) decrease in bacterial binding (Fig. 1) . In control experi ments, we studied the effect of MPCD treatment of epithe lial cells on the attachment of E. coli DH5a, previously demonstrated to be independent of plasma membrane cholesterol (Pucadyil et al., 2004) . As expected, the treat ment of cells with MPCD did not affect the binding capacity of E. coli (2.5 ± 0.9 and 2.3 ± 0.7 E. coli per cell in untreated and MpCD-treated A549 cells, respectively). In order to determine whether the decrease in B. pertussis attachment was specifically due to cholesterol removal, we next replen ished the cholesterol content of MpCD-treated cells by incubation with either cholesterol water-soluble or FBS. The increase in the cellular cholesterol content led to a concomitant increase in the ability of the bacteria to attach to the cell surface (Fig. 1) , underlining the specific require ment of cholesterol in the infection process.
Cholesterol is a major sterol of mammalian cells. More than 90% of cellular cholesterol is located at the plasma membrane. Cholesterol is not uniformly distributed in the membrane, but is preferentially confined to lipid rafts, membrane microdomains enriched in cholesterol, glycoli pids, and glycosylphosphatidylinositol-anchored molecules. Lipid rafts form insoluble complexes (DRMs) upon mem brane solubilization with cold Triton X-100 (Rietveld & Simons, 1998) . We next investigated whether B. pertussis interacts with lipid rafts by subcellular fractionation of A549-infected cells on a sucrose gradient. DRMs are typi cally isolated in low-density fractions. Figure 2a in our experimental setup DRMs were isolated in fractions 3 and 4, in which caveolin, a lipid raft marker, but not transferrin receptor, a cell surface protein typically not associated with lipid rafts, was detected. Bordetella pertussis was found in fractions 3 and 4, suggesting its association with DRMs ( Fig. 2a ). Immunoreactivity of B. pertussis was also observed in fractions 8-12, possibly indicating that B. pertussis also binds to sites that are not located in lipid rafts. Nevertheless, the distribution of B. pertussis in the different fractions and its relative enrichment in DRMs are similar to those found in other pathogens that have been shown to target cholesterol-rich domains (Jutras et al., 2003) . We further investigated this association by confocal microscopy using another lipid raff marker, flotillin. Around 60% of B. pertussis were found to be colocalizing with flotillin-enriched areas, confirming the involvement of lipid rafts in B. pertussis interaction with epithelial cells (Fig.  2b) . Interestingly, Fig. 2b shows that, although less in amount, the characteristic lipid raff spots observed in control cells (panel A) are still present in MpCD-treated cells (panel B), suggesting that lipid rafts were not fully disrupted by this treatment. Remarkably, bacteria attached to cells treated with MPCD, although less in number, were mostly found to be colocalizing with flotillin-positive areas. The significant reduction in B. pertussis adhesion after pretreatment of the cells with cholesterol-sequestering drugs led us to speculate that FHA, reported to be critical for B. pertussis adhesion to A549 cells , could be involved in the interaction of this pathogen with cholesterol. A549 cells were incubated with purified FHA before Triton-insoluble cell components' separation by a sucrose density gradient. Most of the cell-associated FHA was found in low-density fractions, indicating its association with DRMs (Fig. 3a) . Although from these results we cannot rule out that FHA also binds to other molecules or even cholesterol present in the plasma membrane outside DRMs, this figure shows that FHA preferentially targets lipid rafts in the plasma membrane. Importantly, when cell lysates were incubated with saponin, a lipid raft-disrupting drug (Cham berlain et al., 2001) , FHA was no longer detected in low- Purified FHA was incubated with A549 cells for 1 h at room temperature before subcellular fractionation, (a) The gradient fractions were analyzed by immunoblotting using anti-FHA antibodies, anti-transferrin receptor antibodies and anti-caveolin-1 antibodies, (b) FHA-treated cells were lysed using 0.5% Triton X-100 plus 0.5% saponin and analyzed by immune blotting as in (a). Representative results of one out of three independent experiments are shown. Fig. 4 . Cholesterol sequestration affects FHA binding to A549 cells. A549 cells treated with or without 10 mM of MpCD for 15 min at 37 CC were incubated with 17 pg mlA1 of FHA for 1 h at 37 ,;C. After washing, surface-bound FHA was detected by incubation with mouse anti-FHA antibodies, followed by incubation with a fluorescein isothiocyanateconjugated F(ab')2 fragment of goat anti-mouse IgG, and further analyzed by flow cytometry. Cell-associated FHA was determined by the geometric mean of cell-associated green fluorescence. FHA associated with MpCD-treated cells was expressed as a percentage of the level of FHA bound to untreated cells (control) arbitrarily set as 100%. The data represent the mean±SD of three independent ex periments. The level of FHA associated with A549 cells treated with MpCD differed significantly from the level of FHA associated with MpCD-treated cells (*P < 0.05). density fractions, but at the bottom of the gradient (Fig. 3b) . Control experiments showed that purified FHA analyzed directly on gradients is found solely in the bottom fractions of the gradient (data not shown). In parallel experiments, we studied whether FHA association with A549 cells was affected by MPCD treatment. In cells pretreated with MPCD, the total amount of cell-associated FHA was sig nificantly reduced compared with the amount of cellassociated FHA in untreated cells (Fig. 4) . These results, confirmed by fluorescence microscopy (data not shown), suggest that cholesterol-rich domains may function as plat forms that cluster docking molecules for FHA contributing to effective bacterial binding. At least three binding domains have been identified in mature FHA (Locht et al., 1993) , including a heparin-binding domain that mediates attach ment to nonciliated cells, an arginine-glycine aspartate motif that mediates adherence to integrins in leukocytes and a carbohydrate recognition domain that mediates binding to lactosylceramides. Ceramides have been pro posed to be involved in the reorganization of the membrane and/or membrane rafts (Holopainen et al., 1998; Kolesnick et al., 2000) . We speculate that lipid rafts forming an operational attachment platform might ensure a threshold local concentration of lactosylceramides and glycolipids, such as asialo-GMl, that facilitates an efficient bacterial binding.
In order to gain a better insight into B. pertussis interac tion with cholesterol-rich domains, we next explored whether B. pertussis directly interacts with cholesterol. Treatment of B. pertussis with cholesterol before incubation with A549 cells significantly reduced bacterial attachment (Fig. 5a ), indicating that cholesterol, besides stabilizing host rafts, may function as a receptor for these bacteria. The binding of the B. pertussis FHA-deficient mutant (BPGR4) to A549 cells was not affected by cholesterol pretreatment of the bacteria, suggesting that the presence of FHA on the bacteria surface is critical for B. pertussis interaction with this molecule. This result was further confirmed by assessing bacterial adhesion to microtiter plates coated with choles terol. As shown in Fig. 5b , the absence of FHA on the bacteria surface led to a drastic decrease in the cholesterolbinding activity of B. pertussis. Association with cholesterol may stabilize B. pertussis interaction with lipid rafts; how ever, we cannot exclude the possibility that cholesterol outside rafts also participates in B. pertussis attachment to epithelial cells. Furthermore, cholesterol is also a major component of tracheal secretions and its concentration increases under conditions of hypersecretion as during B. pertussis infection (Reid, 1986; Widdicombe, 1987) . Therefore, apart from promoting bacterial attachment to epithelial cells, the cholesterol-binding capacity of B. pertus sis might ensure bacterial colonization via other mechan isms, given the abundant reservoir of cholesterol this pathogen will encounter at the site of infection. 
